Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Total 13F shares
-
1,237,434
-
Share change
-
-2,060,236
-
Total reported value
-
$1,972,853
-
Put/Call ratio
-
0.22%
-
Price per share
-
$1.60
-
Number of holders
-
25
-
Value change
-
-$1,642,896
-
Number of buys
-
10
-
Number of sells
-
8
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q2 2023
As of 30 Jun 2023,
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,237,434 shares.
The largest 10 holders included
MORGAN STANLEY, CITADEL ADVISORS LLC, LPL Financial LLC, Atria Wealth Solutions, Inc., RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, ENVESTNET ASSET MANAGEMENT INC, PVG ASSET MANAGEMENT CORP, GEODE CAPITAL MANAGEMENT, LLC, and Geneos Wealth Management Inc..
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.